About Minovia Therapeutics
Minovia Therapeutics is a company based in Tirat Carmel (Israel) founded in 2011 by Natalie Yivgi-Ohana.. Minovia Therapeutics offers products and services including Mitochondrial Augmentation Technology. Minovia Therapeutics operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Tirat Carmel, Israel
- Founders Natalie Yivgi-Ohana
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Minovia Therapeutics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$350 K (USD), Grant
Aug 27, 2025
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Minovia Therapeutics
Minovia Therapeutics offers a comprehensive portfolio of products and services, including Mitochondrial Augmentation Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology enriches cells with healthy mitochondria to treat mitochondrial diseases.
Unlock access to complete
Funding Insights of Minovia Therapeutics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $350,000
-
First Round
First Round
(01 Oct 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Grant - Minovia Therapeutics | Valuation |
investors |
|
| Oct, 2022 | Amount | Grant - Minovia Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Minovia Therapeutics
Minovia Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Countdown For A Cure. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Minovia Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Minovia Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Minovia Therapeutics Comparisons
Competitors of Minovia Therapeutics
Minovia Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Minovia Therapeutics
Frequently Asked Questions about Minovia Therapeutics
When was Minovia Therapeutics founded?
Minovia Therapeutics was founded in 2011 and raised its 1st funding round 11 years after it was founded.
Where is Minovia Therapeutics located?
Minovia Therapeutics is headquartered in Tirat Carmel, Israel. It is registered at Tirat Carmel, Haifa District, Israel.
Who is the current CEO of Minovia Therapeutics?
Natalie Yivgi-Ohana is the current CEO of Minovia Therapeutics. They have also founded this company.
What does Minovia Therapeutics do?
Minovia provides cell therapy treatment for mitochondrial disease. The company uses Mitochondria Augmentation Therapy (MAT) a proprietary method of isolating mitochondria from white blood cells or placentas. The placental blood of women is used to extract mitochondria, then the cell collection is done, and after that apheresis where doctors can select hematopoietic stem cells from the white blood cells collected and then, over 24 hours, introduce the healthy mitochondria to the stem cells.
Who are the top competitors of Minovia Therapeutics?
Minovia Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Minovia Therapeutics offer?
Minovia Therapeutics offers Mitochondrial Augmentation Technology.
Who are Minovia Therapeutics's investors?
Minovia Therapeutics has 2 investors. Key investors include European Union, and Countdown For A Cure.